Results 71 to 80 of about 343 (127)

QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia. [PDF]

Health Qual Life Outcomes, 2023
Pan T, Wu Y, Buchanan J, Goranitis I.
europepmc   +1 more source

Measuring the Wellbeing of Cancer Patients with Generic and Disease-Specific Instruments. [PDF]

Cancers (Basel), 2023
Chen G, Bulamu NB, McGrane E, Richardson J.   +3 more
europepmc   +1 more source

Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France. [PDF]

Pharmacoeconomics
Pilz MJ, Seyringer S, Nerich V, King MT, Norman R, Gamper EM, EORTC Quality of Life Group.   +6 more
europepmc   +1 more source

Predictors of Vaccine Acceptance, Confidence, and Hesitancy in General, and COVID-19 Vaccination Refusal in the Province of Quebec, Canada. [PDF]

Patient Prefer Adherence, 2022
Nizigiyimana A, Acharya D, Morillon GF, Poder TG.   +3 more
europepmc   +1 more source

Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin's lymphoma. [PDF]

Eur J Health Econ
Xu RH, Zhao Z, Pan T, Monteiro A, Gu H, Dong D.   +5 more
europepmc   +1 more source

Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease. [PDF]

Eur J Health Econ
Xu RH, Luo N, Dong D.
europepmc   +1 more source

China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population. [PDF]

Pharmacoeconomics, 2022
Wu J, He X, Chen P, Xie S, Li X, Hu H, Zhao K, Xie F, CHROME Study Group.   +8 more
europepmc   +1 more source

Mapping to estimate health state utility: a systematic review of development and limitations. [PDF]

Health Qual Life Outcomes
Su Q, Peng X, Zhang Y, Sun L.
europepmc   +1 more source

Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease. [PDF]

Qual Life Res
Bjorner JB, Kennedy N, Lindgren S, Pollock RF.   +3 more
europepmc   +1 more source

Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods. [PDF]

Health Qual Life Outcomes
Jiang L, Li K, Lu S, Hong Z, Wang Y, Xie Q, He Q, Wei S, Zhou A, Kang H, Leng X, Yang Q, Miao Y.   +12 more
europepmc   +1 more source